| Variables |
Number =15 |
| Sex |
|
| Male |
10 |
| Baseline CD4 (median [IQR]) |
121 (45-158) |
| Baseline VL log* (median [IQR]) |
4.6 (3.7-4.9) |
| TB diagnosis |
|
| Culture |
8 |
| Clinical, radiological |
4 |
| Histopathological |
3 |
| TB clinical forms |
|
| Pulmonary |
9 |
| Extrapulmonary |
4 |
| Disseminated |
2 |
| Previous ARV use |
|
| Naive |
1 |
| NNRTI regimens |
9 |
| LPV/r regimens** |
9 |
| Regimens with other PIs*** |
4 |
| Alcohol abuse |
5 |
| Illicit drugs use |
3 |
| BMI<18.5 |
7 |
|
* VL in patients presenting detectable values(n =8/15);
**without resistance;
***atazanavir, indinavir, saquinavir, nelfinavir, ritonavir. |
| Table 1: baseline characteristics of patients included in the study. |
